David M. Knott »

United Therapeutics Corporation shares owned by David M. Knott

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by David M. Knott from 13F filings

Historical chart of David M. Knott investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by David M. Knott consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by David M. Knott

Quarter filed Position value Share count Share price at filing
2021-09-30 $2.8M 15k 184.58
2021-06-30 $2.7M 15k 179.41
2021-03-31 $2.4M 15k 167.24

More positions owned by David M. Knott

Calumet Specialty Products Partners Common (CLMT)
Apollo Global Management Common
Alphabet Inc-Cl C Common (GOOG)
Fortress Trans & Infrastructure Inv Common
Greenidge Generation Holdings Common Put Option
Ligand Pharmaceuticals Incorporated Common (LGND)
Upland Software Common (UPLD)
Coliseum Acquisition Corp Common (MITA)
Kadmon Holdings Common
Midwest Holding Common
Greenidge Generation Holdings Common
Coliseum Acquisition Corp. Wts Common (MITAW)
African Gold Acquistion Corp. Warrants Common
Twelve Seas Investment Company II Common (TWLV)
Pfizer Common (PFE)

View all positions for David M. Knott

Top funds holding United Therapeutics Corporation

Vanguard Group
Wellington Management Company
venBio Select Advisor
Henderson Group
Dimensional Fund Advisors
AQR Capital Management
Bank of New York Mellon
Norges Bank Investment Management
Palo Alto Investors
OrbiMed Advisors
LSV Asset Management
Charles Schwab Investment Management
Pacer Advisors
Caisse de depot et placement du Quebec
Legal & General Group

View all funds holding United Therapeutics Corporation